M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Price:
121.2
SAR
1.68%
Market Closed
Market Cap:
﷼2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
Northwest Biotherapeutics Inc
OTC:NWBO
|
US |
|
Ecograf Ltd
ASX:EGR
|
AU |
|
E
|
Enviri Corp
NYSE:NVRI
|
US |
|
A
|
Audax Renovables SA
XBER:54F
|
ES |
Cash Flow Statement
Cash Flow Statement
Middle East Pharmaceutical Industries Company SJSC
Middle East Pharmaceutical Industries Company SJSC
Currency: SAR
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
66
|
75
|
80
|
80
|
80
|
90
|
93
|
103
|
104
|
|
| Depreciation & Amortization |
12
|
15
|
13
|
17
|
16
|
17
|
19
|
20
|
20
|
|
| Other Non-Cash Items |
14
|
19
|
14
|
28
|
24
|
26
|
22
|
10
|
8
|
|
| Cash Taxes Paid |
6
|
0
|
5
|
5
|
5
|
0
|
6
|
6
|
6
|
|
| Cash Interest Paid |
4
|
5
|
5
|
6
|
4
|
3
|
5
|
5
|
3
|
|
| Change in Working Capital |
1
|
15
|
(2)
|
(51)
|
(84)
|
(105)
|
(88)
|
(31)
|
(44)
|
|
| Cash from Operating Activities |
93
N/A
|
124
+34%
|
104
-16%
|
75
-28%
|
35
-53%
|
27
-22%
|
47
+70%
|
101
+117%
|
89
-12%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(31)
|
(38)
|
(31)
|
(35)
|
(21)
|
(22)
|
(30)
|
(34)
|
(34)
|
|
| Other Items |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
|
| Cash from Investing Activities |
(31)
N/A
|
(38)
-24%
|
(31)
+18%
|
(35)
-13%
|
(20)
+43%
|
(21)
-3%
|
(29)
-40%
|
(33)
-15%
|
(34)
-3%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Debt |
(25)
|
(36)
|
(43)
|
(1)
|
3
|
11
|
30
|
(10)
|
(0)
|
|
| Cash Paid for Dividends |
(36)
|
0
|
0
|
(15)
|
(15)
|
0
|
(40)
|
(47)
|
(47)
|
|
| Other |
(9)
|
(39)
|
(19)
|
(19)
|
4
|
(3)
|
(5)
|
(5)
|
(3)
|
|
| Cash from Financing Activities |
(71)
N/A
|
(75)
-6%
|
(61)
+18%
|
(36)
+42%
|
(8)
+78%
|
(7)
+4%
|
(15)
-102%
|
(62)
-313%
|
(50)
+19%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
(9)
N/A
|
11
N/A
|
12
+10%
|
4
-66%
|
8
+91%
|
(1)
N/A
|
3
N/A
|
6
+113%
|
4
-30%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
62
N/A
|
86
+39%
|
73
-15%
|
40
-46%
|
14
-64%
|
6
-59%
|
17
+186%
|
67
+299%
|
54
-19%
|
|
Switch to:
Switch to:
See Also
Discover More
